Find research datasets worth reusing

opencc-by-4.0May 2009View details →

Figures 827-840. Hind wings. 827 in Morphology of Baridinae and related groups (Coleoptera, Curculionidae)

Figures 827-840. Hind wings. 827, Dryophthorus americanus; 828, Bagous transversus; 829, Cholus rana; 830, Cossonus impressifrons; 831, Curculio pardalis; 832, Hylurgops planirostris; 833, Testalthea sp.; 834, Pacomes distortus; 835, Trichodocerus sp.; 836, Coeliodes flavicaudis; 837, Mononychus vulpeculus; 838, Hypurus bertrandi; 839, Trigonocolus curvipes; 840, Mecopus trilineatus.

opencc-by-4.0Sep 2023View details →

Figs 827–833 in EULOPHIDAE OF COSTA RICA (HYMENOPTERA: CHALCIDOIDEA), 5: The genus Galeopsomyia Girault

Figs 827–833. Head incl. antennae, lateral view ♀ – (827) Galeopsomyia majalis; (828) G. medrosa; (829) G. maya; (830) G. matearis; (831) G. meleadis; (832) G. menoris; (833) G. mesana.

opencc-by-4.0Dec 2011View details →

Figs. 827–839 in The Andean Goblin Spiders Of The New Genera Paradysderina And Semidysderina (Araneae, Oonopidae)

Figs. 827–839. Semidysderina kochalkai, new species, male (827–833) and female (834–839). 827. Carapace, dorsal view. 828, 834. Same, anterior view. 829. Sternum and mouthparts, ventral view. 830. Left embolus, prolateral view. 831. Left palp, prolateral view. 832. Same, ventral view. 833. Same, retrolateral view. 835. Abdomen, lateral view. 836. Same, ventral view. 837, 838. Epigastric region, ventral view. 839. Same, dorsal view.

opencc-by-4.0Dec 2015View details →

FIGURE 16. Shiramine Morphotype B, right mandible SBEI 827. 1–2 in An assemblage of lizards from the Early Cretaceous of Japan

FIGURE 16. Shiramine Morphotype B, right mandible SBEI 827. 1–2, dentary in labial view; 3–4, dentary and associated splenial in lingual view; 5–11, postdentary bones in 5–6 dorsomedial view; 7, ventral view; 8, dorsal view; 9, medial view; and 10, posterior view of articular surface. For abbreviations, see Material and Methods.

opencc-by-4.0Jun 2000View details →

Figs. 826–829. Mesabolivar spp. 826–827. M in New World Pholcid Spiders (Araneae: Pholcidae): A Revision At Generic Level

Figs. 826–829. Mesabolivar spp. 826–827. M. ceruleiventris (Mello-Leitão), female holotype. 826. Epigynum, ventral view. 827. Epigynum, dorsal view. 828–829. M. tandilicus (Mello-Leitão), female syntype. 828. Epigynum, ventral view. 829. Epigynum, dorsal view. Scale lines: 0.3 mm.

ClinicalTrials.gov36/100

Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis

ClinicalTrials.gov study NCT01101100. IPD Sharing: UNDECIDED. Countries: 5. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →

ClinicalTrials.gov36/100

A Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled Asthma

ClinicalTrials.gov study NCT01199289. IPD Sharing: Not stated. Countries: 10. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →

ClinicalTrials.gov36/100

AMG 827 in Subjects With Psoriatic Arthritis

ClinicalTrials.gov study NCT01516957. IPD Sharing: YES. Countries: 2. Publications: 2.

controlledIPD-YESFeb 2026View details →

zenodo32/100

FIGURE 827 in Illustrated key to genera and catalogue of Mymaridae (Hymenoptera) in America north of Mexico

FIGURE 827. Polynema (Doriclytus) sp., habitus. Canada, Ontario, Malborough Forest, 45°05'42"N 75°50'42"W, 26.vi.2002, H. Goulet & C. Boudreault, maple/beech forest. Scale bar=500 μm.

opennotspecifiedMay 2020View details →

ClinicalTrials.gov32/100

Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis

ClinicalTrials.gov study NCT00975637. IPD Sharing: YES. Countries: 0. Publications: 5.

controlledIPD-YESFeb 2026View details →

ClinicalTrials.gov32/100

Study to Evaluate the Safety, PK, PD and Efficacy of AMG 827 in Adults With Rheumatoid Arthritis

ClinicalTrials.gov study NCT00771030. IPD Sharing: Not stated. Countries: 0. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →

ClinicalTrials.gov32/100

Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827

ClinicalTrials.gov study NCT00867100. IPD Sharing: YES. Countries: 0. Publications: 1.

controlledIPD-YESFeb 2026View details →

Figure 3 from: Mahmod AI, Talib WH (2021) Anticancer activity of Mandragora autumnalis: an in vitro and in vivo study. Pharmacia 68(4): 827-835. https://doi.org/10.3897/pharmacia.68.e71695

Figure 3 A plot of change in average tumor size (mm³) vs. time in (days) of treatment in EMT6/P cell line. (P < 0.001) compared to the control group.

Figure 4 from: Mahmod AI, Talib WH (2021) Anticancer activity of Mandragora autumnalis: an in vitro and in vivo study. Pharmacia 68(4): 827-835. https://doi.org/10.3897/pharmacia.68.e71695

Figure 4 Effect of M. autumnalis ethanol extract on tumor size and cure percentage. Treatment with M. autumnalis ethanol extract resulted in reducing tumors size and increasing cure percentage compared to the negative control. (N = 10 mice) in each group.

Figure 5 from: Mahmod AI, Talib WH (2021) Anticancer activity of Mandragora autumnalis: an in vitro and in vivo study. Pharmacia 68(4): 827-835. https://doi.org/10.3897/pharmacia.68.e71695

Figure 5 Effect of M. autumnalis treatment on serum levels of: (A) AST, ALT and (B) Creatinine. Concentrations of AST and ALT are expressed by IU/L and serum creatinine level by mg/dl. Mice were treated with (137.4 mg/kg) of ethanol extract. Creatinine, ALT, and AST levels in normal healthy mouse were 0.8 mg/dl, 47.7 IU/L, 159 IU/L, respectively. Results are expressed as means (bars) ± SEM (lines). ALT, alanine transaminase; AST, aspartate transaminase.

Figure 2 from: Mahmod AI, Talib WH (2021) Anticancer activity of Mandragora autumnalis: an in vitro and in vivo study. Pharmacia 68(4): 827-835. https://doi.org/10.3897/pharmacia.68.e71695

Figure 2 The effect of IC₅₀ concentration of M. autumnalis ethanol crude extract (0.5 mg/ml), n-hexane fraction (0.6 mg/ml) and vincristine (0.02 mg/ml) on VEGF expression in MCF-7 cell line. (* P < 0.01) compared to the control.

Figure 1 from: Mahmod AI, Talib WH (2021) Anticancer activity of Mandragora autumnalis: an in vitro and in vivo study. Pharmacia 68(4): 827-835. https://doi.org/10.3897/pharmacia.68.e71695

Figure 1 (A) Antiproliferative activity of ethanol crude extract of M. autumnalis on MCF-7, MDA-MB-231, EMT6, HCT 116, A549 and VERO cell lines. (B) Antiproliferative activity of n-hexane fraction of M. autumnalis on MCF-7, MDA-MB-231, EMT6, HCT 116, A549 and VERO cell lines. (C) Antiproliferative activity of aqueous/methanol fraction of M. autumnalis on MCF-7, MDA-MB-231, EMT6, HCT 116, A549 and VERO cell lines. (D) Antiproliferative activity of aqueous fraction of M. autumnalis on MCF-7, MDA-MB-231, EMT6/P, HCT 116, A549 and VERO cell lines. Results expressed as means (bars)± SEM (lines).